This podcast provides a comprehensive and detailed account of the rise and ongoing dominance of Novo Nordisk, a prominent pharmaceutical company in the diabetes and weight loss drug markets. It traces the company's history, from its humble beginnings to becoming a global leader in the insulin industry due to the groundbreaking discovery of insulin and subsequent advancements in GLP-1 drugs. The podcast emphasizes Novo Nordisk's unwavering focus on metabolic disorders and its innovative approach ...